ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000937.1|Fosfazinomycin_1 # 1 # 372 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.750	BGC0000937.1|Fosfazinomycin_1 	1	372	-	Loose	450	33.113	BlaB-39	33.33	3005552	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	GTGACGAATGCGGCCGCTCTGCCCGGACAGCCCCGAGGAATCGTTACCTCAGGGCCCGCCACCGCCCGCGCGGTCAACATCCTGGCCCCCAACGCCTCCGCGATGACCCTGGACGGCACCAACACCTGGCTCGTCTCGGAGCCCGATTCCGCGGAAGCCGTCGTCATCGACCCCGGCCCGCTGGACGAGGCCCACCTGCGGGCCGTCGTGGCGGCCGCCGAGCAGGCCGGCAAGCGGATCGCGCTGACCCTCCTCACCCACGGCCACCCCGACCACGCCGAGGGCGCGGGCAGGTTCGCCGAGCTCACCGGTACCAAGGTCCGCGCGCTGGACCCCGCCCTGCGCCTCGGCGACGAGGGGCTCGGCGCCGGG	MTNAAALPGQPRGIVTSGPATARAVNILAPNASAMTLDGTNTWLVSEPDSAEAVVIDPGPLDEAHLRAVVAAAEQAGKRIALTLLTHGHPDHAEGAGRFAELTGTKVRALDPALRLGDEGLGAG	MMKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLGYFGKLGAKTYSTKMTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIVKSGDSKDLGFIGEAYVNNWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEYQQKQKASN	49.80	gnl|BL_ORD_ID|3331|hsp_num:0	4400			189	339	
BGC0000937.1|Fosfazinomycin_3 # 1603 # 2073 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.726	BGC0000937.1|Fosfazinomycin_3 	1603	2073	-	Loose	475	26.1794	ZOG-1	39.22	3007006	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ZOG beta-lactamase	ATGAGCGGCGTCGTCGAGGCGAAGCTGGCCGAGCTCGGCCTGACCCTGCCGGACGTCGTCCCGCCGCTTGCCGCTTACCAGCCGGCCGTGCGGTCGGGCGCGTACGTGTTCACCGCGGGGCAGCTCCCGATGGTCCGCGGCAGTCTGCCGACGACCGGCAAGGTCGGGGCGGAGGTCTCCGCGGAGGAGGCCAAGCAGCTGGCCGCGGTCTGCGCGCTGAACGCCCTGGCGGCGGTGAAGTCGGTGATCGGCGACCTCGACAAGATCGAGCGTGTCGTGAAGGTCGTCGGGTTCGTGGCCTCGGCCCCGGACTTCACGGGCCAGCCGGGCGTGCTGAACGGTGCGAGCGAGCTGCTGGGCGAGGTGCTCGGCGAGAAGGGCGTCCACGCCCGCAGCGCGGTCGGCGTGGCGGTCCTCCCGCTGGACGCCCCGGTCGAGGTCGAGCTCCAGGTCGAGGTTTCCGCTTCCTGA	MSGVVEAKLAELGLTLPDVVPPLAAYQPAVRSGAYVFTAGQLPMVRGSLPTTGKVGAEVSAEEAKQLAAVCALNALAAVKSVIGDLDKIERVVKVVGFVASAPDFTGQPGVLNGASELLGEVLGEKGVHARSAVGVAVLPLDAPVEVELQVEVSAS	MTYKSTVLLLFLITAFFSCKSQQPTLTYSSEDLKIIPLSKNSFVHISYLSTGDFGKVACNGLIYINQGQAVVFDTPTDNETSEELIHWITETKKQQIKAVVINHFHDDCLGGIEAFHELSIPSYASNTTIELAKKEGNPVPQIGFDTTNELTIGKQKIINRHFGEAHTKDNIVSYIPSEHLLFGGCALKSLNAAKGYLGDANTNEWGNTIKKIKAAYPDLKTAIPGHGEYGGSELLDYTISLFSTKQ	63.16	gnl|BL_ORD_ID|4653|hsp_num:0	5724			555	708	
BGC0000937.1|Fosfazinomycin_4 # 2070 # 2255 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.661	BGC0000937.1|Fosfazinomycin_4 	2070	2255	-	Loose	550	23.483	SHV-124	66.67	3001171	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	GTGTCACGCGTTACGCTCGCCCCCATGACCAAGAAGTTCGAATACGCGACGGTCCCGCTGCTGGTCCACGCCACCAAGCAGATCCTGGACACCTGGGGCGAGGACGGCTGGGAGCTCGTCCAGGTCGTGCCCGGGCCGAACAACCCCGAGCAGCTCGTGGCCTACCTCAAGCGGGAGAAGGCATGA	MSRVTLAPMTKKFEYATVPLLVHATKQILDTWGEDGWELVQVVPGPNNPEQLVAYLKREKA	MRYIRLCIISLLATLPLAVHASPQPLDQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQ	22.51	gnl|BL_ORD_ID|808|hsp_num:0	877			36	81	
BGC0000937.1|Fosfazinomycin_5 # 2265 # 3284 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000937.1|Fosfazinomycin_5 	2265	3284	+	Loose	1300	28.1054	optrA	27.27	3003746	protein homolog model	n/a	n/a	oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGCGCAGCCCGAGGGGCGAGTGGTTAGGCTCAGACGCTGTGAGCAGGCTCCAGGTGGTCAGCGGCAAGGGCGGAACCGGAAAGACCACGGTCGCCGCGGCACTCGCGCTCGCCCTCGCGCGCGAGGGCAGGCGGACGCTGCTGGTCGAGGTCGAGGGCAGGCAGGGGATCGCGCAGCTCTTCGGGGCCGAGGCGCTCCCGTACGAGGAGCGGAAGATCGCCGTCGCCTCGGGCGGCGGGGAGGTCTTCGCCCTGGCCATCGACGCCGAGCGGGCGCTGCTCGACTACCTCCAGATGTTCTACAAGCTCGGATCCGCCGGCCGCGCCCTCAAGAAGCTCGGCGCCATCGACTTCGCGACGACCATCGCGCCCGGCCTGCGGGACGTCCTGTTGACCGGCAAGGCGTGCGAGGCGGTCCGGCGCAAGGACAAGGCCGGGCGCTACGTCTACGACCACGTGATCATGGATGCGCCGCCGACCGGGCGGATCACCCGGTTCCTGAACGTCAACGACGAGGTGGCGGGACTGGCCCGGTTCGGGCCGATCCACAACCAGGCGCAGGCCGTCATGAAGGTGCTCAAGTCCCCGGAGACGGCCGTCCACTTGGTCACGCTGCTGGAGGAGATGCCCGTCCAGGAGACCGCCGACGGGATCGCCGAGCTGGAGGAGGCCGGACTGCCCGTCGGGCGGGTCGTCGTCAACATGGTGCGGCCGCACCACCTGGACGAGGACACCCTGCGCGCCGCCGCCGGCGAGCGCCGGGCGGACGTGGCCAAGGCGCTGTCCCGGGCGGGCCTGGGCGGCGCGCGGCGCGGCGGGCTCGCCGAGCGGCTGGTGGACCCGCTGCTCGCGCAGGCCGCCGAGCACGCGAGCCGGGTGGAGCTGGAGCGCGCGCAGCGCACCGTACTGGAGGAGCTGGACGTGGCGACGTACGAACTCCCCCTGCTCGGCGCGGGGATGGATCTGGCCGGGCTCTACGAGCTGGCCTCGGAGCTGCGGAAGCAGGCGGGCGACGCATGA	MRSPRGEWLGSDAVSRLQVVSGKGGTGKTTVAAALALALAREGRRTLLVEVEGRQGIAQLFGAEALPYEERKIAVASGGGEVFALAIDAERALLDYLQMFYKLGSAGRALKKLGAIDFATTIAPGLRDVLLTGKACEAVRRKDKAGRYVYDHVIMDAPPTGRITRFLNVNDEVAGLARFGPIHNQAQAVMKVLKSPETAVHLVTLLEEMPVQETADGIAELEEAGLPVGRVVVNMVRPHHLDEDTLRAAAGERRADVAKALSRAGLGGARRGGLAERLVDPLLAQAAEHASRVELERAQRTVLEELDVATYELPLLGAGMDLAGLYELASELRKQAGDA	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	51.76	gnl|BL_ORD_ID|2069|hsp_num:0	2263			150	405	linezolid; chloramphenicol; florfenicol; tedizolid
BGC0000937.1|Fosfazinomycin_6 # 3281 # 4597 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000937.1|Fosfazinomycin_6 	3281	4597	+	Loose	1050	26.5646	carA	53.57	3002817	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGACCGAAGCCACGACGGGAATGACGGCAAGGAAGACCGGCGCGGGCCTGGACGCTCCCCCGCGGCTGCCCGTGGACCGGCTGCTGGACGACCCCGGGACGCGGATCATCGTCTGCTGCGGCGCGGGCGGGGTCGGCAAGACCACGACCGCCGCGGCCCTCGGCGTACGGGCGGCGGAGCGCGGGCGGAAGGTGGTCGTGCTGACCATCGACCCGGCGCGGCGGCTCGCCCAGTCGATGGGGATCGACTCGCTGGACAACACCCCGCGCAGGGTCAAGGGGGTCCAGGGAGCCAAGGGGGTCGACGGTGCGGACGGCGGCGAACTGCACGCCATGATGCTCGACATGAAGCGGACCTTCGACGAGATCGTCGAGGGGCACGCGGACGCCGAGCGGGCGGAGGCCATCCTCGCCAACCCCTTCTACCAGTCGCTGTCGGCCGGCTTCGCGGGCACGCAGGAGTACATGGCGATGGAGAAGCTGGGCCAGTTGCGGGCCCGCGACGACTGGGACCTGATCGTCGTGGACACCCCGCCGAGCCGGTCCGCGCTGGACTTCCTCGACGCGCCGAAGCGGCTGGGGTCCTTCCTGGACGGGAAGTTCATCCGCGTGCTGATGGCTCCGGCGAAGGTGGGCGGCCGGGCGGGGATGAAGTTCCTCAACGTCGGCATGTCCCTGATGACCGGCACGCTCAGCAAGCTGATGGGCGCCTCGCTGCTGAAGGACGTGCAGACGTTCGTGGCGGCGATGGACACGATGTTCGGCGGGTTCCGCACCCGCGCGGACGCGACGTTCCGGCTGCTCCAGGCTCCGGGTACGGCCTTCCTGGTGGTCGCGGCGCCCGAGCCGGACGCGCTGCGGGAGGCGGCGTACTTCGTGGAGCGGCTGGCCGCGGAGAACATGCCGCTGGCCGGGCTTGTGTTGAACCGGGTGCACGTCAGTGGCGCCGATCAGCTGTCCGCGGAGCGGGCGTTGGCCGCCGCAGAGAATCTTGAAGAGGGCGGCATTGTCGATCAGGAGTCCGGGAATGCTGGACTTCGTGACTCGGCCGCGGAGGCTGAAGCGGCGGACGCCGACGTGGCGGGGGCCGACGCGGCGGACGCCGATGTGGACGAGATCACCGCAGGACTGCTGCGTCTGCACGCCGAGCGGATGCAGGTGATCGCGCGAGAACAGCGCACACGGGATCGTTTCACCTCGCTGCACCCCGAGGTGGCGGTGGCCGAGGTGGCCGCCCTGCCCGGCGATGTGCACGACCTCGCCGGGCTACGGGCCATCGGAGAGCGACTCGCGGCCGGGGTGCCGGCCGGAGCGTAG	MTEATTGMTARKTGAGLDAPPRLPVDRLLDDPGTRIIVCCGAGGVGKTTTAAALGVRAAERGRKVVVLTIDPARRLAQSMGIDSLDNTPRRVKGVQGAKGVDGADGGELHAMMLDMKRTFDEIVEGHADAERAEAILANPFYQSLSAGFAGTQEYMAMEKLGQLRARDDWDLIVVDTPPSRSALDFLDAPKRLGSFLDGKFIRVLMAPAKVGGRAGMKFLNVGMSLMTGTLSKLMGASLLKDVQTFVAAMDTMFGGFRTRADATFRLLQAPGTAFLVVAAPEPDALREAAYFVERLAAENMPLAGLVLNRVHVSGADQLSAERALAAAENLEEGGIVDQESGNAGLRDSAAEAEAADADVAGADAADADVDEITAGLLRLHAERMQVIAREQRTRDRFTSLHPEVAVAEVAALPGDVHDLAGLRAIGERLAAGVPAGA	MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA	79.49	gnl|BL_ORD_ID|853|hsp_num:0	928			1107	1188	carbomycin
BGC0000937.1|Fosfazinomycin_8 # 5505 # 7811 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.690	BGC0000937.1|Fosfazinomycin_8 	5505	7811	+	Loose	1300	229.18	Helicobacter pylori pbp1 mutants conferring resistance to amoxicillin	27.26	3007060	protein variant model	N107R, S543T, I450V	V562L:2886, A501T:3628	cephalosporin; cephamycin; penam	antibiotic target alteration	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	ATGGGAAAGAAGCGCTCGGGCGCCGGGCTCACGGGGCCGCAGCAGGCCGCCAAGTTCCTCGGGGTGTCCGTTCTCTCCGGAGTTGTGCTGGCCGGCATCGCGATCCCGGGCGCAGGCGCCCTGGGGCTCGCCGCCAAGGGAACGGTCGAGGGATTCGACGAGATCCCGGCCAATCTCAAGACACCGCCGCTGAGTCAGCGCACGACGATTCTGGACGCCGAGGGTGGCTTGATCGCCACGGTCTATTCACGGGACCGGCAGGTGGTGCCGCTCACGGCTATCTCCCCGTACATGCAGAAGGCGATCGTCGCGATCGAGGACTCGCGTTTCTACGAGCACGGCGCGATCGACGCGAAGGGCATCCTGCGCGCGGTCAACCGCAACGCGCAGGAGGGCGGGGCCGCGCAGGGCGCCTCCACGCTGACGCAGCAGTACGTGAAGAACGTGTTCGTCGAAGAGGCCGGCGATGACGAGACCAAGGTGCGAGAGGCCCAGGAGAAGAGCCTCGGCCGCAAGATCCGCGAGCTGAAGTACTCGATCCAGGTCGAGGAGGAGCTCGGGAAGAAGAAGATCCTCGAGAACTACCTCAACATCACGTACTTCGGCCAGCAGGCATACGGAATCGAATCCGCCGCCCAGCGCTACTTCAGCAAGCCGGCCAAGGACCTGACCCTGGACGAGTCGGCGCTGCTGGCGGGCGTGGTGCAGTCGCCGAGCCGGTTCGACCCGGTGAACGACGCGCAGGAGGCGATGAAGCGCCGCAACGTCGTCCTCCAGCGGATGGTCGACATGAAGGACATCTCGCAGGCCGAGGCGGACGAGGCGAAGAAGAAGCCGGTGACGCTGAAGGTGACGCGGCCGAAGAACGGCTGCATCACCGCCGTCAAGGGCGCGGGCTTCTTCTGCGACTACGTGCGCAACACGTTCCTGACCGACCCGGTGTTCGGCAAGACCCGCGAGGAGCGGGCCAAGCTCTGGAACCAGGGCGGCCTGACCGTGCGGACGACGCTGGACCCGCAGTCGCAGGAGTCCGTCAACGAGTCGATCAAGGATCACGTCAACCAGGACGACAAGGTCGCCACGGCCGTGACCCTGGTGCAGCCGGGCACGGGCCGGGTCCTCGCCATGGGCCAGTCCAAGCCGTACGGCTTCGGGAAGAACGAGACGCAGATCAACTTCTCGGTCGACAAGCGGATGGGCGGATCGAACTTCGGCTTCCCGACCGGTTCGACCTTCAAGCCGTTCGTCGCGGCCGCGGCCCTGGAGAAGGGCGTGTCCCCGGGCAAGACGTACCCGTCCCCGCACGACATGGAGTACCCGAGCCCGGTGGAGACCTGCGGCGACAAGCCGTGGGTCAACACCTCCCACGACCGGGTCGAGAACGAGTCGGAGTCCGAGCGCGGCCCGTACGGCATGCAGGACGCGATGGCCAAGTCGGTCAACACGTACTTCGTGGAGATGATCTCCGAGAACGGGCTCTGCCCCGTGACCGAGATGACCACCAAGCTCGGCGTGATCCCGGCCGACGGGACGAAGCTGCCGGAGGTCCCGGCGATCGCGCTCGGCACCGAGGGCATGTCCCCGCTGACCATGGCGAACGCGTACGCGACCTTCGCCAACCGCGGCGTGTACTGCACCCCCGTCGCCCTGGAGTCCATCACCGACGCGCACGGCAAGGCGCTGGCCGTGCCGAAGTCGCAGTGCGACCGCGTGATGAGCGAGAAGACCGCCGACACCGTCAACACGCTGCTGCTCGGCGTGATCGACTCCGGTACGGGTACCGCGGCGGGTCTGACCGACCGGCAGAACGCGGGCAAGACCGGCACCACCGACAGCCGCTACAACGCCTGGTTCGTCGGGTACACGCCGAACATGGCCGGTGCGACGTGGGTCGGCTCGGGCGGCGCGAAGCAGGTGTCGATGGAGAACATCACCATCGGCGGCCAGTACTACGACAAGGTCTACGGCGGCGGGCTGCCCGGCCCGATCTGGAAGCAGGCGGTCTCGGGCGCGCTGTCGGGCCGGGAGGCGCCGACGTTCACCACGGTCGGCATCCCGGAGAGCGGCGGCGCGCCGACGGGCGGCGGCCGGCCCAGTACCCCGAACCCGAACCCGAACAAGCCGGGGAAGCCCGGCAAGCCGGGCGGCGACGGCAAGCCCGGCGGCCGCCCCGGCGGTCAGACGGCGGCGGGGGCCACGGGCGGCCCGACGGGTGGCTTGACCGGCGGGGCGACCGGCGGCGCGACGGGCGGCGGCACCCCGACCGACCCGTTCCCGGGCGGCGTGATCGGCGGCCTTGAGGACTAG	MGKKRSGAGLTGPQQAAKFLGVSVLSGVVLAGIAIPGAGALGLAAKGTVEGFDEIPANLKTPPLSQRTTILDAEGGLIATVYSRDRQVVPLTAISPYMQKAIVAIEDSRFYEHGAIDAKGILRAVNRNAQEGGAAQGASTLTQQYVKNVFVEEAGDDETKVREAQEKSLGRKIRELKYSIQVEEELGKKKILENYLNITYFGQQAYGIESAAQRYFSKPAKDLTLDESALLAGVVQSPSRFDPVNDAQEAMKRRNVVLQRMVDMKDISQAEADEAKKKPVTLKVTRPKNGCITAVKGAGFFCDYVRNTFLTDPVFGKTREERAKLWNQGGLTVRTTLDPQSQESVNESIKDHVNQDDKVATAVTLVQPGTGRVLAMGQSKPYGFGKNETQINFSVDKRMGGSNFGFPTGSTFKPFVAAAALEKGVSPGKTYPSPHDMEYPSPVETCGDKPWVNTSHDRVENESESERGPYGMQDAMAKSVNTYFVEMISENGLCPVTEMTTKLGVIPADGTKLPEVPAIALGTEGMSPLTMANAYATFANRGVYCTPVALESITDAHGKALAVPKSQCDRVMSEKTADTVNTLLLGVIDSGTGTAAGLTDRQNAGKTGTTDSRYNAWFVGYTPNMAGATWVGSGGAKQVSMENITIGGQYYDKVYGGGLPGPIWKQAVSGALSGREAPTFTTVGIPESGGAPTGGGRPSTPNPNPNKPGKPGKPGGDGKPGGRPGGQTAAGATGGPTGGLTGGATGGATGGGTPTDPFPGGVIGGLED	MLKKIFYGFIVLFLIIVGLLAILIAQVWVTTDKDIAKIKDYRPGVASQILDRKGRLIANIYDKEFRFYARFEEIPPRFIESLLAVEDTLFFEHGGINLDAIMRAMIKNAKSGRYTEGGSTLTQQLVKNMVLTREKTLTRKLKEAIISIRIEKVLSKEEILERYLNQTFFGHGYYGVKTASLGYFKKPLDKLTLKEIAMLVALPRAPSFYDPTKNLEFSLSRANDILRRLYSLGWISSNELKSALNEVPIVYNQTSTQNIAPYVVDEVLKQLDQLDGLKTQGYIIKLTIDLDYQRLALESLRFGHQKILEKIAKEKPKTNASNEDEDNLNASMIVTDTSTGKILALVGGIDYKKSAFNRATQAKRQFGSAIKPFVYQIAFDNGYSTTSKIPDTARNFENGNYSKNSKQNHAWHPSNYSRKFLGLVTLQEALSHSLNLATINLSDQLGFEKIYQSLSDMGFKNLPKDLSIVLGSFAISPIEAAEKYSLFSNYGTMLKPMLIESITNQQNDVKTFTPMETKKITSKEQAFLTISVLMNAVENGTGSLAHIKGLEVAGKTGTSNNNIDAWFIGFTPTLQSVIWFGRDDNTPISKGATGGVVSAPVYSYFMRNILSIEPSLKRKFDVPKGLRKEIVDKIPYYSTPNSITPTPKRTDDSEERLLF	116.54	gnl|BL_ORD_ID|4762|hsp_num:0	5758			12	1743	amoxicillin
BGC0000937.1|Fosfazinomycin_10 # 8417 # 9355 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000937.1|Fosfazinomycin_10 	8417	9355	+	Loose	1000	27.335	MCR-2.4	43.75	3007283	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGCGTGCGCGTTACGGAGTACCCCTGAAGGTCACGGCGTCGATCGCGGCGGTGGGGGCCGCCGGTGTGGCCTATGCCGCCGGTTTCGAGGCGCGGTCGTTCCGGCTGCGCCGGATCACCGTGCCGGTGCTCCCCGCCGGGATGCGCCCGCTGCGCGTGCTCCAGGTCTCCGACATCCACATGGTCGGCGGGCAGCACAAGAAGCGCGCCTGGCTGCAGTCGCTGGCCGGCCTGCGGCCGGACTTCGTGGTGAACACGGGGGACAACCTCTCCGACACGGAGGGCGTTCCGGAGGTGCTCGACGCCCTGGGCCCCCTGATGTCCTTCCCGGGGGTGTACGTCTTCGGGTCGAACGACTACTACGGGCCGCGGCTGCGCAACCCCGGGCGCTACCTGATCGAGAAGGTCCAGGGGCGGCACGGGCTGAACGGCAACAAGCCGGTCGTCGGCGCCGTGCACAACCCGTGGGAGGAGATGCGGGACGCCTTCGACGCGGCGGGCTGGGTCAACCTGACCAACACCCGCGGCCGCCTGAAACTGCCCGGCCTGGAGCTCGCCTTCACCGGGCTCGACGACCCGCACATCAAGCGCGACCGCTACGAGCGGGTCGCGGGCGGGCCGGAGGCGGACGCCGACTTCTCGATGGCGGTCGTGCACGCCCCGTACCTGCGGGTCCTGGAGTCCTTCACCGCCGACCGCTACCCGCTGATCCTGGCCGGGCACACGCACGGCGGGCAGCTGTGCATCCCCTTCTACGGGGCGCTCGTCACCAACTGCGACCTGGACACGAAGCGGGTGAAGGGGCTCTCCACGCACGAGGCGAACGGGCACCGCGCCTACCTCCACGTCTCGGCAGGCTGCGGCACGAACCGCTACACCCCGGTCCGCTTCGCCTGCCCCCCTGAAGCCACCCTCCTGACGCTGACCCCGAAGGCGTAG	MRARYGVPLKVTASIAAVGAAGVAYAAGFEARSFRLRRITVPVLPAGMRPLRVLQVSDIHMVGGQHKKRAWLQSLAGLRPDFVVNTGDNLSDTEGVPEVLDALGPLMSFPGVYVFGSNDYYGPRLRNPGRYLIEKVQGRHGLNGNKPVVGAVHNPWEEMRDAFDAAGWVNLTNTRGRLKLPGLELAFTGLDDPHIKRDRYERVAGGPEADADFSMAVVHAPYLRVLESFTADRYPLILAGHTHGGQLCIPFYGALVTNCDLDTKRVKGLSTHEANGHRAYLHVSAGCGTNRYTPVRFACPPEATLLTLTPKA	MTSHHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVALMGAMLLIVVLFSYRYVLKPVLILLLMMGAVTSYFTDTYGTVYDTTMLQNALQTDQAESKDLMNLAFFVRIIGLGVLPSIVVAWVKVDYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASFFRVHKPVRFYINPITPIYSVGKLASIEYKKATAPKDTIYHAKDAVQTTKPSERKPRLVVFVVGETVRADHVQFNGYSRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVDILWRDNNSDSKGVMDKLPATQYFDYKSATNNTICNTNPYNECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNTSFKPTASDTALTHDAITPTLLKLFDVTAGKVKDRTAFIQ	57.99	gnl|BL_ORD_ID|4895|hsp_num:0	5888			1290	1386	colistin A; colistin B
BGC0000937.1|Fosfazinomycin_12 # 12124 # 12825 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.725	BGC0000937.1|Fosfazinomycin_12 	12124	12825	+	Loose	2090	31.5722	mdsB	37.18	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACAGCCCATCTCTACTGGGACGAGGTCTGGCGCACCGACAGCGGGCGCACAGGCGACTGGTCGCGGCCGCACCCGTGGGTCGTGGACGAGGCCGCGCGACTGCGGAAGCTCGGCGCGCAGGACGTACTGGACCTCGGCTGCGGCGTGGGCCGGCACGCCCTCTGGTTCGCGGAGGCCGGGTTCACCAGCTCCGGCACCGACGCCAGCGAGGCGGCGGTGCGCGCCGCCCGCGAGGAGAGCGAAGAGCGCGGGGTGCGGGTCGCCCTCGACATCGGCGACTTCGGCGAACTCCCCCACCCGGACGCCAGCTTCGACTACGTCCTCGCCTTCAACGTGGTCTACCACAACGACGAGGCGGGCCTCGGCCGCGTGCTCGACGAGGTCCGGCGCGTCCTGCGCCCGGGCGGCATCTACCAGTCCACGATGCTCTCCAAGCGCAACGGCGAGTACGGGCGCGGCATCGAGGTGAGCCCCAACACCTTCCGCCAGCCCGGGGCCACCGACGACAAGGTGCACCCGCACCTGTACGTGGACGCCGCCGACCTGCTGCGCCTGCACCCTGGGTTCCGCCTGCTCAGTGCCACCGACGCCGAGCACGCCACGCCCGGCTCCTTCCACTGGCACTGCGTGTTCGAGTCGGCGGGGGAGGACGTGGCGGGCACGCACCACGGCCGTTTCGCGCAGAGGGCCGGGGAATAG	MTAHLYWDEVWRTDSGRTGDWSRPHPWVVDEAARLRKLGAQDVLDLGCGVGRHALWFAEAGFTSSGTDASEAAVRAAREESEERGVRVALDIGDFGELPHPDASFDYVLAFNVVYHNDEAGLGRVLDEVRRVLRPGGIYQSTMLSKRNGEYGRGIEVSPNTFRQPGATDDKVHPHLYVDAADLLRLHPGFRLLSATDAEHATPGSFHWHCVFESAGEDVAGTHHGRFAQRAGE	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	22.09	gnl|BL_ORD_ID|1269|hsp_num:0	1385			489	696	chloramphenicol
BGC0000937.1|Fosfazinomycin_15 # 14809 # 15570 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.728	BGC0000937.1|Fosfazinomycin_15 	14809	15570	+	Loose	1000	25.0238	MCR-8.3	45.45	3007227	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGACCACCGTCATCGCCCATGTCAGCGATCTGCACCTGGACCTCTCGGAGCGCGCCACCCAGCGCGCGCTGACGGTCATGAACCACCTGCGTGACATGCCCGGACCCGTCGACGCCGTCCTGGTCTCCGGGGACATCGCCGACCACGCGACGGCGGACGAGTACGCGCAGGCCCGCAAGTTGTTGGACCTGCCCTACCCGGTGCTGGTGCTGCCCGGCAACCACGACCGGCGGGGTGCGTTCCGTACGGGCCTGCTCGACGCCGCGCCCGGGGACGAGGAGCTGAACCAGGTCGTCCGCACGCCCGGAGCCGTCTTCCTGCTGTGCGATTCGACGGTGCCGGGCAGCGACGAGGGCCTGCTCAGCGACCTGACCCTGGGGTGGCTGGACGAGACACTGACCGCCGAGGGCGGGGAGCTGCCCGTCTTCGTCTGCTTCCACCACCCGCCGGTCGACCTGCACACCCCGTACGTGGACCGGGTCCGGCAGTTCGGCGAGGAGCGCCTCGCCGCGGTGCTGGAACGGCATCCGCAGGTCGTGGCCCTGCTGTGCGGTCACGCGCACGTGGCCGCGGCCACGACGTTCGCGGGGCGCCCGCTTCTCGTGGCGCCCGGGGTCGCCTCGACCGTCCCGCTGCCCTTCGAGGGCCGGCCTGCCGTGGACTACGAGCTGGCCCCGGCGCTGGCCTTCCACGTACTCGACGACCGGCGGCGGCTGGTCACGCACTACAGGGCGCTCGGCCGGCCGCACCCCGAGCACTGA	MTTVIAHVSDLHLDLSERATQRALTVMNHLRDMPGPVDAVLVSGDIADHATADEYAQARKLLDLPYPVLVLPGNHDRRGAFRTGLLDAAPGDEELNQVVRTPGAVFLLCDSTVPGSDEGLLSDLTLGWLDETLTAEGGELPVFVCFHHPPVDLHTPYVDRVRQFGEERLAAVLERHPQVVALLCGHAHVAAATTFAGRPLLVAPGVASTVPLPFEGRPAVDYELAPALAFHVLDDRRRLVTHYRALGRPHPEH	MFKYLLSFKLNPVQRTWAAAFFFTTIGNIALWQTLWINVDVHNIHNLLFFASLPIFLFCFLSILLTPVMVIPYLCRPLLVVLILISACCSYFMMKYNILIDRSMVQNFFETNQAELTSYLSVPFLSTLFLLGIVPAIILALPSTDNKRGAFRIELWWLAHICIAVVLLAMVTMVFYKDYASLIRNNMQIKDQALPFNFVRNTNGYLKRKYQASSTILQSVGEDAVRPIYSNAPPKLVVVVVGETARAQNFQLNGYSRVTNPYLSRRHDVISFKNVSSCGTATAISLPCMFSRMSRNEYNEVRAASEENLLDILKRTGVEVLWRNNNNGGCKGICKRVPTDDMPAMKVIGECVNKDGTCFDEVLLNQLSSRINAMQGDALIVLHQMGSHGPKYFERYPSTSKVFSPTCDSNLIEKCSNKELVNTYDNTLVYTDRMLSKTIELLQRYSGMRDVAMIYLSDHGESLGESGIYLHGTPYIIAPNEQTHIPMFMWFSSSFAQHSKLNLECLTGNADKQYSHDNFYHSILGLFNVKTSVYKPELDMFTLCRQSDHTPLSSAVVREKTDGNG	44.78	gnl|BL_ORD_ID|4835|hsp_num:0	5832			399	465	colistin A; colistin B
BGC0000937.1|Fosfazinomycin_16 # 15658 # 17055 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.763	BGC0000937.1|Fosfazinomycin_16 	15658	17055	+	Loose	350	39.6614	vanP	29.17	3007189	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGAGAAGAGTCCTGATCGCCAACCGCGGTGCGATCGCGGCCCGGGCCGTCGACACCTTCCGCACGCTGGGCTGGTCGCCGATCGCCGTCGTCGCCTCCTCGGATCCCCAGCGCCTGCACGCGCTCGCCGCGGACGGGTGCGCGTACCTCGAAGGCACCGGGCTCGCGCAGACGTACGACCACGTGGGCCGGATCGTCGAGGCGGCCCGGCGCTGCGGCGCCGACGCGGTGTACCCGGGCTACGGGGCGCTGGCGGAGGACCCGGAGCTGCCCGAGCGGCTGGCGGCGGCGGGCATCGCCTTCATCGGGCCGACGGCGGAGGTGCTCGCGGCGGCCCGCGACAAGGACCACGCGGTCGCCACCGCCGACCGGCTGGGCCTGCCCGTGCTGCCGCACGCGACCGGGCACGAGCGCATCGCCAAGCTGGTGGCGGACATCGGGCTGCCGGTCATCCTCAAGCCGGTCACCGGGTGCGGCGGCCTCGGCGTGCGCATCGTGCGCACCGGGGCGGAGGCCGAGCGGGCGCTCGCGCTGATCGCCTCCGACGAGGCCGGCGGCGCGGGTGGCGGCGCGGGCACGGGCACGGGCGCGGGCACGGGCACGGGCGACGCCTGGTACGCCGAGCGGTACGTGGAGCGCGGAGCGGTGGTCGGGGTCACCGTCGCCGTGGACGACGCCGGGACCGTGCACCCGCTCGGTGAGCGGGAGAGCCTGCTGGTCGACGGCAGCATGAAGCTGCTGGAGGCCTCGCCCGTCCAGGGCGTGGCCCCGGAGCTGGTGGAGCGGATGCGGGCGGACACGGCCCGGCTCGTCACCGGGATGGGGTTGCGGGGCGTGGCGACGGTCGAGTTCATCGTCGGCTCGGGCGACGGTGCCGCTGCCGGCGGGGCTGCGGATGCGGGTGCGGGTGCAGGTGCCCGAGCCCGCGGTCACTACTTCCTGGAGGTCAACGGGCGGCTGCCGCTGGCCTACCGGATGTGCGAGGCGCAGACCGGCCTGGACCTGGTGGCCCTCCAGATGGAGCTGGCGCAGGGCGCGCTGCCCGCCCCCGGCCGCATCCGCGTCGACCGGGACACGCACTGCCTGGAGGCGCGCCTGTTCATCGAGCCGGCGCCGGACGGGGCGCCCGGCCGGATCACCGACCTGGAGCTGGCCCCCGAGCCGGGGGTGACGTACAACTGCGCGCTGGACGTGCGCAGGCCGGTCGTCCTCGACAACATCGTCACGCAGGTCCTGGCCCTGGGCGAGCGCCGCGCCGTGGCGGCCGGGGCGGTGCTGCGGGCCGTCGCGGGCAGCGGGGTGTCGGGGGTCGGAACGTGCGCGGAAGAGATAGCCGTGTGGCTGCGGGGTTCGGGGCTGGTCCCGGAACGCCTCGGCAGCCAGGCCTTGGGAGTCTGA	MRRVLIANRGAIAARAVDTFRTLGWSPIAVVASSDPQRLHALAADGCAYLEGTGLAQTYDHVGRIVEAARRCGADAVYPGYGALAEDPELPERLAAAGIAFIGPTAEVLAAARDKDHAVATADRLGLPVLPHATGHERIAKLVADIGLPVILKPVTGCGGLGVRIVRTGAEAERALALIASDEAGGAGGGAGTGTGAGTGTGDAWYAERYVERGAVVGVTVAVDDAGTVHPLGERESLLVDGSMKLLEASPVQGVAPELVERMRADTARLVTGMGLRGVATVEFIVGSGDGAAAGGAADAGAGAGARARGHYFLEVNGRLPLAYRMCEAQTGLDLVALQMELAQGALPAPGRIRVDRDTHCLEARLFIEPAPDGAPGRITDLELAPEPGVTYNCALDVRRPVVLDNIVTQVLALGERRAVAAGAVLRAVAGSGVSGVGTCAEEIAVWLRGSGLVPERLGSQALGV	MRKVLVLFGGCSEEHDISVKSATEVYHYIDKQKYDVTYVGITKDGRWRKVNSPKEPLEESKTMAILSPDTGKKGILLIEENTYTLQEIDVIFPVMHGKMGEDGQLQGIMELSGIPYVGCDIESSVIAMDKSLANMVADRAGILVPWFMAKNDVKEFDADILPYPVFVKPARSGSSFGISKVENREQFADAVKEALQYDSKILVEEAIQGQEVACAIMGRGEELLTGEVDMVQVKNGFFRIHQEKNPEGGSENAVITVPAPLDMPATERIKKEAKKIYKALGCKGLARVDMFLTKEGRIVLNEVNTLPGMTCYSRYPAMMKAAGIEFTDMVERLIEEALGANA	135.96	gnl|BL_ORD_ID|4819|hsp_num:0	5805			264	549	vancomycin; teicoplanin
BGC0000937.1|Fosfazinomycin_17 # 17062 # 18015 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.731	BGC0000937.1|Fosfazinomycin_17 	17062	18015	+	Loose	750	26.5646	tet(51)	26.8	3004586	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAACAGCAACGATCCGTTCTCGACCGTCCGCCACTCCGTCGACCGCGCGCTCGCGACGGCCCTCGCCGAGAGCGGGGAGGAGGACGTACGCGCGCACTGGTACCGGGAGTTCGGGCGGACCGTCGGTGGTCACGTACGGCGCCACCTCGACGCCCGGCCCGGCTTCTTCGTACTGAGCGGCCTGGACCACCTGGACGAGGAGCAGGCGCGCCGGTTCACGGTCGCGGTCTCCCGGCTGGCAGGGGACCTGCTGCCGCAGGACGGCGCGGGAGCGCTGCTGCGGGACGTACGGGACCGGGGGGTGCGGCTCGGGGAGGGCGCGACGGGCCGCTACTCGGACAGCCGTCAGGGCGGCAGCCTGCACACCGACGCGGCGCACCGGCCGGGGCGGCTTCCGGACATTTTCGCGCTGTTCTGCGTCCGGCAGGCCTCCAGCGGCGGGGCCCTGGTCACGGTGCACGTGAGCGATCTGCTGGAGATCCTCCGGGACCACCCCGGGGAACTCGCCGCGCTGCGGCTGCCGGTCCACTTCGACACCCGGGACGACACGCCGGGGGTGCCGCTCACGACCGAGCGGCCGGTACTGGAGTTCAAGGACGGCCGGGAGCGGATGTACTACCTGCGGGACTACATCGAGATCGGGCACCGGCACCCGCACGTACCGCAGTTGACGCCCGAGCAGATCAAAGCGCTGGACCTGCTGGACTCGCTGCTGGAGCGGCGCGATCTGCAGACGCACGGCCGACTGGCACCGGGCGAGATGATCTTCATCGACAACCGGTCGATCGTGCACGGCCGGACGGCGTTCGACGAGGCCCGGCCGGTGGACGGCGGGCGGCTGATGCTCCGCACCTGGATCGGTCTCCGGGAGCGGCGCGGGTCCGCAGCCGGAGCCGGAGCCGGGGCGGACACCGGCGCAGGGGCCGGCACCGACGCAGGGGCCGTCCGGTGA	MNSNDPFSTVRHSVDRALATALAESGEEDVRAHWYREFGRTVGGHVRRHLDARPGFFVLSGLDHLDEEQARRFTVAVSRLAGDLLPQDGAGALLRDVRDRGVRLGEGATGRYSDSRQGGSLHTDAAHRPGRLPDIFALFCVRQASSGGALVTVHVSDLLEILRDHPGELAALRLPVHFDTRDDTPGVPLTTERPVLEFKDGRERMYYLRDYIEIGHRHPHVPQLTPEQIKALDLLDSLLERRDLQTHGRLAPGEMIFIDNRSIVHGRTAFDEARPVDGGRLMLRTWIGLRERRGSAAGAGAGADTGAGAGTDAGAVR	MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE	81.91	gnl|BL_ORD_ID|2723|hsp_num:0	3288			222	447	tetracycline; oxytetracycline
BGC0000937.1|Fosfazinomycin_18 # 18012 # 19061 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.762	BGC0000937.1|Fosfazinomycin_18 	18012	19061	+	Loose	400	27.335	VIM-8	33.33	3002278	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	GTGACACGGCTCGTCGCCGAGCTCGAACGACTCGGCCTCGCCGAGTTCCTCGCCGACTTCCCCGGGGACTCGGTGGACCGCCGCCAGTGGGCCGCCGGCGCCCGCGGCCTCGACGGTGAGCTGCGCGCCCTCGCCGGGTTCCTGCTGCTCGGGGAGCCCGCGGCGGCCGACCGGCTGCCGCCCGCCCTCGCCGGGGCGCTGCCCTCCCTGGTCAAGAGCGGGGTCGCGCACCAGCGCGGGGCCGAGGTCCGGCTGATCGACGTCAGCCTGTTCCGCTCCGCCGGGGTGTGGCTGTTCGCGGAGCCGCCGAGCCCCTTCCCCGTACGCCACTACTTCGGCCGGGACTCGATCGCGCTGGCCCGGCGCACCGGCTTCCGGGCGGGGGAGCGGGTCCTCGACCTGTGCTCCGGGCCTGGGTTCCAGGGGCTGGTCGCCGCACACGGCGGCGCCCGGGCCACGCTGGTGGAGCTGCTGCCCGAGACCGCCGAAGTGGCCCGGCTCAACGCGGAGATCAACGGGGTGGCCGACCGGATCGAGGTCCTCGTCGGCGACCTGTACGAGCCGCTGCCGGCCGGGGCGCGTCCGTACGACCACGTCATCGCGAACATCCCCTTCCTGCCGACCCTCGCGACCCCGGGCGAGGAGGCCGCCCACGAGGGCGGCGAGGACGGGTTCGGCGTGGGCCGCCGGGTCCTCGCCGGGCTCCCCCGGCACCTGGGCGCGGGCGGTACGGCCCATCTGACCGCGCTCCTCCTCCAGGGGGACGAACAGCTCGTCACGGACGGCGAACTGCGGGCCTGGGCCGCGGCGAACGGGTACGGCCTGACGGTCACGCTGACCGAGCGGATGGCGGTGGACGCCGACTCCGACCTCGTCCAGACGACGGTGTCGGACCACCTGGAGACCGACCCGGGGGCCGACCCCGAGGAGCTCACCGCCGCCGCCGTCGCCGCGTACGCGAGCCGCGGGGCGACGGCCGCCCGACTGGCCTATCTGCGGATCGACGCCGGGATGGCCGACTTTCGTGTCCTCGACCGCGCGGGCGGGTGA	MTRLVAELERLGLAEFLADFPGDSVDRRQWAAGARGLDGELRALAGFLLLGEPAAADRLPPALAGALPSLVKSGVAHQRGAEVRLIDVSLFRSAGVWLFAEPPSPFPVRHYFGRDSIALARRTGFRAGERVLDLCSGPGFQGLVAAHGGARATLVELLPETAEVARLNAEINGVADRIEVLVGDLYEPLPAGARPYDHVIANIPFLPTLATPGEEAAHEGGEDGFGVGRRVLAGLPRHLGAGGTAHLTALLLQGDEQLVTDGELRAWAAANGYGLTVTLTERMAVDADSDLVQTTVSDHLETDPGADPEELTAAAVAAYASRGATAARLAYLRIDAGMADFRVLDRAGG	MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSARRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE	131.20	gnl|BL_ORD_ID|234|hsp_num:0	262			216	429	
BGC0000937.1|Fosfazinomycin_19 # 19114 # 20394 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.737	BGC0000937.1|Fosfazinomycin_19 	19114	20394	+	Loose	500	25.7942	sul2	33.87	3000412	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	GTGACGACGGCAGGGACGGACGGCGCGGGCAACGGCGGCACGGCACACGGCACGGGCGGCAGCAGCAGCGGCAACGGCGGCAGCGGCAGCGGCAGCGGCAGCGGCTCGAAGGGCCCGGAGCTCGTCGAGCTCGTCGAGCTCACCTCGATACGGGACGCGGAAGCCGACCGGTGGAACGCCCTCGCGGGTGACGCCGCCCTCTACTCGACCCACCGCTGGCTGCTCTACGGCGAGGAGCTGGCCGACGCCGGCTCCCGCCACCTGGTCGCCGCCCCCGGCGGCTCGTACACCGTCGGGCTCCCCACCCACCGCTTCACCGGGGAGGTCCCGCACTTCTACGATCCCGCCGTGCTGTTCCCCGGCGCCGCCGAGCCGGCCACGCCCGAGCGCCCGCTGCTCCTCGGCGGCACCCGCCTCGGCTACACCAGCGAGGTGATCGTCGCCCCGGGCACCGCCGAGCCGCTCGCCGCGGCGGGCGTACGGACCGTACTGGACCGGTTCCGCGCGCTGGGCGCCGACGACGGCGGCCTCGCGGCCCTGCTCTACCTCACCGACGAGTCGGTGGAGCGGCTGCTGCCGCACCTGGGCCCCCGGGACCAGGTGGTGATGATGGACGCGACCGCCGTCCTGCCCGTCGATCCCGACGGCCTGGAGGGCTACCGCAGGCGCTTCACCTCGCACCAGTTCACCTCCATCCGCCGCGAGATGCGCCGCTACACCGACACCGGCTGCCGCACGGAGGTCAAGCGCCTCTCCGAGTGCCACCACCTGCTCGGCCCGCTCTCCGCGCAGGTGCTCATCCGCTACGGGCACCCCGTCACCGACGAGAGCGAGTCGGAGCGCTTCGCCCAGCAGGCCTCGCTGTTCGACGACAACTGCCGGATCCTGGGCGCCTACCAGGGCGACCGGATGGTGGGCTTCACCCAGTACTTCTTCTGGGGGAACACCATGTACGCCCGCTCGCACGGCCTGGACGACTCCATCGCCCGCGAGGCCAAGCTCTACTTCAACCTCACCTACTACGAGGCCGTGAAGTACGCGGCGGCCCACGGCTACCACTGCGTGGACCTGAGCTGCGACGCCTTTCAGGCCAAGGTGTCCCGGGCCGCCCGGCTCCAGCCCCTGTGGGGCGTCGTCCTCGACGCCCCGTGGACCGGGCCGGCCTTGGAGCGCGTACGCGCCGAGGAGCGGGCCCGGCGCCAGGAGTACGCCTCCCACGACCCGGGGATCGAGTCGCGGGTGGCGCGGCTCGTGGACGCGCGCGCCCGCGACAGGGCGTAG	MTTAGTDGAGNGGTAHGTGGSSSGNGGSGSGSGSGSKGPELVELVELTSIRDAEADRWNALAGDAALYSTHRWLLYGEELADAGSRHLVAAPGGSYTVGLPTHRFTGEVPHFYDPAVLFPGAAEPATPERPLLLGGTRLGYTSEVIVAPGTAEPLAAAGVRTVLDRFRALGADDGGLAALLYLTDESVERLLPHLGPRDQVVMMDATAVLPVDPDGLEGYRRRFTSHQFTSIRREMRRYTDTGCRTEVKRLSECHHLLGPLSAQVLIRYGHPVTDESESERFAQQASLFDDNCRILGAYQGDRMVGFTQYFFWGNTMYARSHGLDDSIAREAKLYFNLTYYEAVKYAAAHGYHCVDLSCDAFQAKVSRAARLQPLWGVVLDAPWTGPALERVRAEERARRQEYASHDPGIESRVARLVDARARDRA	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	157.20	gnl|BL_ORD_ID|874|hsp_num:0	952			369	546	sulfadiazine; sulfadimidine; sulfadoxine; sulfamethoxazole; sulfisoxazole; sulfacetamide; mafenide; sulfasalazine; sulfamethizole
BGC0000937.1|Fosfazinomycin_20 # 20426 # 21661 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.739	BGC0000937.1|Fosfazinomycin_20 	20426	21661	-	Loose	500	45.8246	tet(59)	26.63	3004441	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCGAGCGACGGACGGAGCCTGAGACGCGGCCTGGCGGCCGCACTGTTCGTCCGCTACCTCGGGGCGGGCAGCTGGGCCCCTCTCCAAGTCCTGTTCTTCGTCCGGTCCGTGGGCCTGTCCACGGGCAACGTGGTCATGGGGCTGACGGCGGCCGGGCTCGCGGGCCTGGTCGCCGGGCCGCTCGTCGGCCGGCTCGCCGACCGGTTCGGGCCGCGCGAGGTGGGCATCGCCGGACTGGTCGCCCAGGCGGCCGCCGCCGGCGCGCTGCTGCTCGTGGAGGGCATGGCCGGGTTCCTCGTGGTGATCACCCTGATCGCCCTGGGGCGCGGCGCCTTCCCCGCGATCAGCGGCGCGCTGATCGCGTACGTCGGCGGTGAGGACCGGGTCGCCTACCGGGCACGGATCTACTCCCTCCAGAACCTCGCGATGGTCTCCGGTTCGCTGCTCGGCGGGCTGGCGCTGCAGGCCGACACCCGGACCGCGTACGTGATCGCGATCTGCGCCGACGTCGTCTCGTACCTCGTCGCCGCGGTGCTGGTGGCGCGGCTGCCGCACCTGCCGCCGATCCCCAAGGAGCCGGGCAGCGGCCGCCACTACGCGCTCGCCGACCGCCCGTTCCTCGCCGTCAGCGTGCTCGCGGGCACCCTCGTCATGTTCGACGTCTTCATGACGGTGCTGATGCCGGTGTGGATCGCCGAGTACACGAAGGCGCCGCGCTGGACGGTGTCGCTGGTCTTCGCGCTGAGCTGCGCGCTGGTGGTCCTGCTCCAGACCAAGGTGGCCAAGGGGGTCGAGACCCCGCGCGACGGTGCGCTGGCCATGCGGCGCAGCGGGCCCGTCATCGCCGTGGCCATGGCCCTCGTCTTCGCCGCCGCGCACCTCCCGATGTACGCGGCGATGGGGCTGATCCTGATCGGCACGGCGGCGCTGACCTTCGGGGAGATGCTGTTCACGGCGGGGGAGTACGCCCTGTCGTTCGGGCTGGCCCCCGAGCACGCGCAGGGCGAGTACCAGGGCGTGTTCTCCGTCGGGGTCGGCATCGGCGGTGCGGTCGCGCCGACCGTGCTGAACGCGCTGTGCCTGGGCGCGGGCCCGGTGGGGTGGGCCGTGCTCGTCACCCTCATGGTCGCGGCCGGGGCGGCGGTGCCGCCGGTGGCTGCGATCGCGGAGCGCGGGCGCGACCAGCGGGAGGGGAACCGCGAGAAGGAGCGGGAGCCCAGACCGGCCGGGTGA	MPSDGRSLRRGLAAALFVRYLGAGSWAPLQVLFFVRSVGLSTGNVVMGLTAAGLAGLVAGPLVGRLADRFGPREVGIAGLVAQAAAAGALLLVEGMAGFLVVITLIALGRGAFPAISGALIAYVGGEDRVAYRARIYSLQNLAMVSGSLLGGLALQADTRTAYVIAICADVVSYLVAAVLVARLPHLPPIPKEPGSGRHYALADRPFLAVSVLAGTLVMFDVFMTVLMPVWIAEYTKAPRWTVSLVFALSCALVVLLQTKVAKGVETPRDGALAMRRSGPVIAVAMALVFAAAHLPMYAAMGLILIGTAALTFGEMLFTAGEYALSFGLAPEHAQGEYQGVFSVGVGIGGAVAPTVLNALCLGAGPVGWAVLVTLMVAAGAAVPPVAAIAERGRDQREGNREKEREPRPAG	MNKFAITALTITALDAMGIGLIMPVLPTLLREYVSAENLANHYGILLALYAIMQVFFAPLLGKWSDKFGRRPILLLSLAGAAVDYTLLALSSSLWMLYVGRLISGVTGATGAVAASVIADNTASQERTKWFGRLGAAFGIGLIAGPAIGGFTGQFSAHLPFIIAAILNALSFLVIMLIFKDNKIKNTEKNTTETAENSRPFLQVIKPVILLLFIFFMTQMIGQIPATTWVLFTEHRFQWGSMEVGLSLAGLGIMHALFQAFVAGAIAKKFNEKVTIIVGFVVDGAAFIILSLLTKGWMIYPTLILLAGGSIALPALQGLMSAQVNQTNQGKLQGVLVSLTNTTGVIGPLLFSFIFGQTLASWDGWIWMIGAIMYVLLIVFILSFYRSTKKIVKIAKLPAS	102.75	gnl|BL_ORD_ID|2491|hsp_num:0	2881			174	663	tetracycline; chlortetracycline; oxytetracycline
BGC0000937.1|Fosfazinomycin_21 # 21661 # 22356 # -1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.731	BGC0000937.1|Fosfazinomycin_21 	21661	22356	-	Loose	650	29.261	tetA(58)	32.5	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGATCGTTGCGATGGACGGACCCGACGGCGCGGGCAAGAGCACGCAGGTCAAGCGGTTGCAGAGCTGGGCCGAGGGCCAGGGCCTGTCGTTCCGCGTCGTCGGCAAGTGGCAGGTGTTCGCGGAGTCGGAGGTACCGCAGGCCCGCTTCCTGCGCGGCACCACCCTCGACGAACTGCGGGTCTGCATCGCCGAGATGCCGAACCCGGCCCGGATGCTCTTCCTCGGCTGGCTCAACACCCTGGCCGCGGAGCGCGCCCGCGCCGCCGAGGCGGACCTCGTCGTCCTCGACGGCTACTGGGTCAAGCACGCCGCCACCGAACTGCTGGCGGGCTGCCCCCAGGAGCTCGTGGACGCGATCGTCCACGCCATGGCCCCGGTGGACAGCGTCGTCTTCTTCGACGTCACCCCCGAGGAGGCGCTGCGCCGCAAGAAGGGCGACATCACCCCGTACGAGTGCGGCCGCGACCCGGAGTGCCGGCCGGAGAGCTTCCTGTCCCACCAGGCGGCCGTCCGGGAGGTCATGCTCGACTGGGCGGCCCGGCGCGGCTGGGACGTCGTACGGGCGAACACCGCCGAGGCGGCGGCGCAGCAGCTGCGCAAACTGCTGGCGCCCAAGCTGGGGGTCGAGGTCAACCCCCGCCCCGCGGAGGCCGCTCCCCGTCCCGCAGCCGTCGACGCCCCGGCGGGCCACTGA	MIVAMDGPDGAGKSTQVKRLQSWAEGQGLSFRVVGKWQVFAESEVPQARFLRGTTLDELRVCIAEMPNPARMLFLGWLNTLAAERARAAEADLVVLDGYWVKHAATELLAGCPQELVDAIVHAMAPVDSVVFFDVTPEEALRRKKGDITPYECGRDPECRPESFLSHQAAVREVMLDWAARRGWDVVRANTAEAAAQQLRKLLAPKLGVEVNPRPAEAAPRPAAVDAPAGH	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	67.35	gnl|BL_ORD_ID|2243|hsp_num:0	2517			132	363	tetracycline
BGC0000937.1|Fosfazinomycin_22 # 22406 # 23884 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.788	BGC0000937.1|Fosfazinomycin_22 	22406	23884	-	Loose	1900	29.261	mexN	25.62	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACCGCCCCACGACACCTCCGGACACGGGTCTCCTTTCGCCGGTCCGGGCCGGTACCGCCACCGAGGCGGCCCTCACCGACACCGCCTGGGCCCAGGCGATGCTCGACGCCGAGGCCGCCCTGGCCCGGGCCCAGTCCCGGCTGGGCACCGTGCCCGCGAAGGCCGCCGAGACGATCACGGCGTGCGCCCGGGCGGGGGCGATCGACCTGCCCGCGCTGGCCGTACGGGCGCGCGGGGCCGCCAACCCGGTGGTCGCCCTGGTCGAGGAGCTGACGGCGCTGGTCGCGGCCGCGGACCCCGCGGCGGCGGAGTACGTGCACCGCGGTTCCACCAGCCAGGACGTCCTCGACACCGGCGCGATGCTGGTCACGGCCCGCGCGCTGCGCCTCGTACGCACCGAGCTCGACCGGACGGCCGAGGCGCTGGCCGGGCTGGCCGACGCGCACCGGGGGACGCCGGCGGTGGCCCGGACCCTCGGCCAGCACGCCGTCCCCACCACGTTCGGCCTCAAGGCGGCGGGCTGGCTCGTCGCCGTGGTCGACGTACGGCGCCGGGTCGGGGCCCTGCTCGACGGGGGGCTGCCGGTCCAGCTCGGCGGGGCCGCGGGCACCCTCGCGGGCTATCTGGAGTACGCGCGGCTGACGCCGGCCCGGGCGGGCGCGGCCGCCGGTACGTACGGGGACACGGACGCCGGTACGCACGCGGACACGGCCGCCGGCGCGTACGCCGGGGAGCTGATCGCCCTCTTCGCCGCCGAGACGGGACTCGCGGAGCCCGTCCTGCCCTGGCACACCCTGCGCACCCCGATCGGCGACACGGGCGCCGTCCTCGGGCACGCCGCCGCGGCGCTCGGTAAGTTCGCCACCGATGTGCAGACCCTGGCCCGCACCGAGCTCGCCGAGGTGGCCGAACCCGCCGGGGCCGGCCGCGGCGTCTCCTCCGCCATGCCGCAGAAGCGCAACCCGGTGCTCGCCGCGATGATCCGCTCCGCCGCCCTCCAGGTGCCCCCGCTGGTCCTCACGCTGACGCAGTGCGCGGCCGCCGCCGAGGACGAGCGGCCCGCCGGGGCCTGGCACGCCGAATGGCAGCCGCTGCGCGAGGCGCTGCGACTGGTGGGCGGGGCCGCCTGCACCGCGGCGGAGCTGGCCGAGGGGCTGGAGGTGCGTCCCGCGCGGATGGCGGCCGGCCTGCGGCTCACCGGCGGGGCCGTCGTCACCGAGCGGCTGGCCGCCGCGCTGGCCCCCGTACTCGGCAAGGCGGGCGCGAAGCGCCTGGTCGCCCGGGTGGCCGTGGACGCGGCGACGGCGGACCCCGCGGACTCCCTCGTCGGGCGGCTCCTCGCCGCCGCACCCGAACTGGCCGGGGAGTTCACCGCCGCGCAGCTGGAGCGGCTGCTCGACCCGGCCGAGTACACCGGCGCCGCCGGGGCGCTGATCGAGCGGGCTCTCGCCTACCACCGCGGCAGCACCGCATGA	MDRPTTPPDTGLLSPVRAGTATEAALTDTAWAQAMLDAEAALARAQSRLGTVPAKAAETITACARAGAIDLPALAVRARGAANPVVALVEELTALVAAADPAAAEYVHRGSTSQDVLDTGAMLVTARALRLVRTELDRTAEALAGLADAHRGTPAVARTLGQHAVPTTFGLKAAGWLVAVVDVRRRVGALLDGGLPVQLGGAAGTLAGYLEYARLTPARAGAAAGTYGDTDAGTHADTAAGAYAGELIALFAAETGLAEPVLPWHTLRTPIGDTGAVLGHAAAALGKFATDVQTLARTELAEVAEPAGAGRGVSSAMPQKRNPVLAAMIRSAALQVPPLVLTLTQCAAAAEDERPAGAWHAEWQPLREALRLVGGAACTAAELAEGLEVRPARMAAGLRLTGGAVVTERLAAALAPVLGKAGAKRLVARVAVDAATADPADSLVGRLLAAAPELAGEFTAAQLERLLDPAEYTGAAGALIERALAYHRGSTA	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	47.49	gnl|BL_ORD_ID|2021|hsp_num:0	2217			1980	2328	chloramphenicol; thiamphenicol
BGC0000937.1|Fosfazinomycin_23 # 23884 # 25851 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.774	BGC0000937.1|Fosfazinomycin_23 	23884	25851	-	Loose	700	28.4906	oleD	31.03	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGAGTACTTCGGCACGTACTGACGAACACGGCGACGGGGAGGGCCGGCTGACGGTCTGCGTCATCGGGTCGGGCCCGCGGGGGCTGTCCGTCCTGGAGCGGCTGGCGGCCAACGCGGACGAGCTGCTGCCGCCCGGGGTGCGGCTGCGGGTCCACCTCGTCGACCCGCGGCCGGGCAGCGGGCAGGTGTGGCGCTCCGACCAGTCGCGCCACCTGCTCATGAACACGGTCGCCTCCCAGGTGACCCTGTTCACCGATGACAGCGTGACGATGGACGGCCCGGTGCGGCCCGGCCCCAGCCTGGCCGTGTGGGCCGCCGACCCCGCCCAGCACGGCGGCGCCTCCCCGGCCGGGGACGAGGTGCCGGGGCCCGACGGCTATCCCACCCGGGCCCTGTACGGGCGCTACCTGGAGTGGGTGCTGCGCGGCGTGGTCCGGCGGAGCCCGGCGGACATCCGGACCCACCCCGCGCGGGCCGTCCGGCTCGACGCGGATCCGGCCGGTCCCGGCGCCCGCGCGCCCGGCCGCGACCGGGTGACCCTGGACGACGGCACGGTGCTGTCCGGGCTCGACGCGGTGGTCCTGGCCCAGGGGCACCTGCCGGTCTCCCCGGCCCCCGCCGAGGCCGCCCTCGCGCGCTTCGCGGCCCGCCGCGGGCTCTGCTACCTGCCCCCGGGGAACCCCGCCGAGGCCCGGCTCGACGGGATCGCGCCCGGGGAGCCGGTCCTGCTGCGCGGCCTCGGGCTCAACTTCTTCGACCACATGGCCCTGCTGACGGAGGGCCGCGGCGGGGTCTACGAAGCCAAGGACGCCGGGCTCGTCTACCACCGCTCCGGGCACGAGCCCGTGCTGTACGCGGGATCGCGCCGGGGGGTGCCGTACCAGGCGCGCGGGGAGAACCAGAAGGGCGCGCACGGCCGCCACCGCCCGCTCGTCCTCACCCCGGCGGCGGTGGCCCGGCTGCGCCGGGGGCCGCGGCGGCCCGGCTTCCGGAGCGACATCTGGCCGCTGGTCGCCCAGGAGGTCGAGACCGTCCACTACGCCGCCCTGCTGCGGGCCGGCGGCCGCCCCGAGGCCGCGGCGCACCTGCTCGAACGGAGCGCCGGCGGGCCCTGGACCGCGTACGAGCGCGACCGGCTGCTCGACGCGCTGGGCGTGCCGCCCGGGCGGCGCTGGGACTGGGACCGGGTCGCCCGGCCCTGCGCGGACCGCGTCTTCGCCGACCGCGCCGCGTTCACCGGGTGGCTGCTGGAACACCTGCGCCGGGACGTGGCCGAGGCGCACGCCGGGAACGTCGACGGCCCGTACAAGGCGGCCCTGGACGTGCTGCGCGACCTGCGCAACGAGGTGCGGCTGCTGGTCGACCACGGCGGGATATCCGGCGCCGATTACCGAGACGAACTGACCGCCCGCTACGGGCCGTTGAACGCCTACCTGTCGATCGGCCCGCCGCCGCGCCGGATCCGGGAGGCGATCGCGCTGATCGAGGCCGGTGTGCTGACCGTCCTGGGCCCGGGGGCGGAGTTCGGCGCGGACGAGGCCGCCGGCCGTTTCACCGCCCGCTCGCCCCGGGTCGGCGGGGGCGCGGTGCACGCGCGGGCGTTCATCGACGCGCGGCTGCCCGAGCCCGATGTGGTGCGCACCGAGGACCCGCTGCTGGGGTACCTGTACGCCACCGGCCAGTGCGTCCCGTACGTGATCGACGGCGAGGACGGCCCGTACCGGACCGGCGGGATCGCGGTCACCGAGCGCCCGTACCACGTCATCGACGCGGCGGGGGCGGCGCACGAGCGGCGCTTCGCGTACGGCGTGCCCACCGAGGGCGTGCACTGGGTGACCGCGGCCGGGGCCCGGCCGGGCGTCGACTCGGTGATCCTCGGCGACTCCGACGCCATGGCCCGCGCCGTCCTCGGCCTCGCCCGCGGGGCGGACCGCCGCTTCGACTCGCTGACGAGGAGCACCACCTGA	MSTSARTDEHGDGEGRLTVCVIGSGPRGLSVLERLAANADELLPPGVRLRVHLVDPRPGSGQVWRSDQSRHLLMNTVASQVTLFTDDSVTMDGPVRPGPSLAVWAADPAQHGGASPAGDEVPGPDGYPTRALYGRYLEWVLRGVVRRSPADIRTHPARAVRLDADPAGPGARAPGRDRVTLDDGTVLSGLDAVVLAQGHLPVSPAPAEAALARFAARRGLCYLPPGNPAEARLDGIAPGEPVLLRGLGLNFFDHMALLTEGRGGVYEAKDAGLVYHRSGHEPVLYAGSRRGVPYQARGENQKGAHGRHRPLVLTPAAVARLRRGPRRPGFRSDIWPLVAQEVETVHYAALLRAGGRPEAAAHLLERSAGGPWTAYERDRLLDALGVPPGRRWDWDRVARPCADRVFADRAAFTGWLLEHLRRDVAEAHAGNVDGPYKAALDVLRDLRNEVRLLVDHGGISGADYRDELTARYGPLNAYLSIGPPPRRIREAIALIEAGVLTVLGPGAEFGADEAAGRFTARSPRVGGGAVHARAFIDARLPEPDVVRTEDPLLGYLYATGQCVPYVIDGEDGPYRTGGIAVTERPYHVIDAAGAAHERRFAYGVPTEGVHWVTAAGARPGVDSVILGDSDAMARAVLGLARGADRRFDSLTRSTT	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	157.83	gnl|BL_ORD_ID|1253|hsp_num:0	1367			477	636	erythromycin; tylosin
BGC0000937.1|Fosfazinomycin_25 # 27385 # 28887 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.772	BGC0000937.1|Fosfazinomycin_25 	27385	28887	-	Loose	1100	30.8018	oleB	33.8	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGCGCCTGACCTGCCCGCCCCACCTGCCCTGCCCGCCCCACCTGACCCGGCCGCATCGCCGTTCGCCGGCATCCGGGCTCTCCGCGCCGCCTACGGGGACGGCAGCCTGCTGCCCTCGGAGCACCTCGCCGCCACCTTCGGGCTGCTGGACCGGTGGGAGCCCCGGATCGGCGCCTTCCTCACGCTCGCCCGTGAGCGCGCCACCGCCGAGGCCGAGGCCGCGGACCGGCTGCTCCACCGGTACGGGAACGCCGTCTGGCGGGACCGGCCGCTGCTCGGCATGCCCGTCTCCGTCAAGGACCTGACCCCGACGGAGGGGATCCGGACCACCCGCGGCTCCCTCCTGAACGCCGACGCCGTGCCCGGCCGGGACGCCCCGGCCGTGGCCCGGCTGCGGGCGGCAGGCGCGATCGTCATCGGCAAGACCAACACCTCCGAGGGCGGCTGGAGCGCGGCCGGCGCCAACCGGCTCCAGGGCCCGACCCGCAATCCGTGGGACCCCGCCCGCACCCCCGGCGGCTCCAGCGCCGGTGCGGCCGCCTCGGTGGCCGTGGGCATCGGGGTCGGCGCCACCGGCACCGACGGCGCCGGGTCGATCCGCATCCCCGCCGCCTTCTGCGGGGTCGTCGGGTTCAAACCCACGCTGGGCCGGATCCCGTACGTGCCCCAGAGCCCGGACGAGCTGTCCCATCTGGGGCCGCTGACCCGGACGGTGGCCGACGCGGCCCTGCTCACCCAGGTGATGTCCGGCTACGACACCGCCGACCCGCTGTCCTTCGGGGTACCCGGCGAGCCGGCCGGGGACCTGGAGGAGGCGGCCGGGCTCCTGCCCCGCCTGCGCATCGGCTGGATCCCCTCGCTCGGCGATCCCGCCCCGCCGCCCGGCATCGCGGCCGTCGCCCGGCGGGCGGTGGAGGCGCTGGCGGACCGGGGGCACGCGGTCGAGGAGATCCCGCCGCCCTTCGAGGACCCGTACCCGGCCCTGGAGACGATCCTGGCGGGCTGGGAGGCGGCCGCCCACCCCCGGGACCTTGACGAGGTCGCGGACCGCCTCGACCCCGGCCGGCTCCGCGTCATCCGGTACGGGCGCACGCTCAGCGCCGCCCGGCTGGCCCGGGCGTACGAGGCGCGCGGCCGGCTGCGGGCCCTCAGCCAGGCCCTGATGGAGCGGTACGACCTGCTGGCCATGCCGACCGTGGCCATCGCGCCGTTCGCCGCCGACCTGCACGAGCCGCCGGACCCGGTCCGCAAGGGCGCCCTGTCCTGGCTGGCGTGGGCCCCCGAGGCCTACACCTTCAACCTGACCGGCCAGCCCGCCGTGTCCGTCCCGGCGGGGCTGTCGCCCGAGGGCCTGCCCGTCGGACTCCAACTGGTCGGCGGGCGGGGCGAAGACCTGCGGGTCCTGGCCGCCGCGTACCAGCTGGAGCAGGTGCGGCCCTGGCACCACCACTACGCGGAGCTCTCGGCCCGATCGCCGGAACCGGAAGAGGAATCGACATGA	MAPDLPAPPALPAPPDPAASPFAGIRALRAAYGDGSLLPSEHLAATFGLLDRWEPRIGAFLTLARERATAEAEAADRLLHRYGNAVWRDRPLLGMPVSVKDLTPTEGIRTTRGSLLNADAVPGRDAPAVARLRAAGAIVIGKTNTSEGGWSAAGANRLQGPTRNPWDPARTPGGSSAGAAASVAVGIGVGATGTDGAGSIRIPAAFCGVVGFKPTLGRIPYVPQSPDELSHLGPLTRTVADAALLTQVMSGYDTADPLSFGVPGEPAGDLEEAAGLLPRLRIGWIPSLGDPAPPPGIAAVARRAVEALADRGHAVEEIPPPFEDPYPALETILAGWEAAAHPRDLDEVADRLDPGRLRVIRYGRTLSAARLARAYEARGRLRALSQALMERYDLLAMPTVAIAPFAADLHEPPDPVRKGALSWLAWAPEAYTFNLTGQPAVSVPAGLSPEGLPVGLQLVGGRGEDLRVLAAAYQLEQVRPWHHHYAELSARSPEPEEEST	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	87.87	gnl|BL_ORD_ID|1272|hsp_num:0	1388			108	315	oleandomycin
BGC0000937.1|Fosfazinomycin_26 # 28877 # 30463 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	BGC0000937.1|Fosfazinomycin_26 	28877	30463	-	Loose	1900	33.4982	MexI	35.23	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGGCTCGGCGAGCGCGTGTACACGGAGATCGCCGAGTCCCAGGTCGCGGGCTTCGCCCCGACCGGCGGCCCCGACACCGCGGCGGACGAGGGCGGCGGGGACCTGCTGGTCCTGACCGGGACCGGGCGGCTGCGCGTCGTCCCGGCCGGCACCCGGCCGGCCGGCCCCGAGGAGGCCGAGCCGCTCGGCACCCTCAAGTGGCAGAACAGGCCGGAATCCCTGGGCCGGCTGTGGGCACTGGCCCAGGACGTCCAGCGGATCCAGTTCGAGGAGGTCCACCGCTGGCTCGCCCAGCAGGACGCCGGTTCCGTCCGGGAGCGGATCGACGCGGTGGGCCACGCGCTGCTCCACATGGCCCCCGTGCTGCTGTACGTGGGCGACCGCTTCTACAGCAACCTCGGCAAGTTCAGCAATCTGCCCGGCCGTTCGCTGGCCGCCGGGGCGGAGCGCTCCGTGCTCACCGCGCTCCGGGCAGCCCCGGCCGCCCGGTGGGCCCCCGAGGACGCCACCTTCGTGGTCTGCCTGAACGCGCTCATCAGCTCGGGCTCCCCCGTCCGGGCCGAGGAGTTCAACGGGGTACAGCTCACCCCGGACCTGCTCGCGGGCTTCCTCCGGGAACGCATCGAGACGTACGGGGCCCCGGTCCCGGACCTCGCCGGCCGGCCGACGGGCGCCGCGCTCGACGCCCTGGCCGCCGCCTGCGCCGCCGCGCGGGCGGAGCGGTTACGCGCGGGCGCCGTGTTCTACCGCGAGATCAACGGTGCCTCCCTGCACAAACGCGAGCGGATCATGGCCGAGCCGCTCGGCTGGGACGAGCTCCCGGCGCCGGTGGCGGGGCTGCTCTCCGGCGCCGCGGGCCGGCCCTTCCCCGTGGCGGCCGCGCCCGCGACGGTACGGGCGTACGCCGGGGAGGTCGTGGAACGCGTCGTACGGCTCGCCGCGCCCACCGGGTTCACCAGCGCCTACGAGGGGTTCCTCCACCGCTTCTTCGAGACGCTGGCCGGGGCACTGGACTGCGACGTCGTGATGGGCCGGGGACCCAAGAGCGTCGCCGTCCTGCACAGCGGCCACCCGGCCGAGGACCGGATCGCCCTGGCCACCCGCGATTTCTACTGCTGCGTCGCGCCCGGCGCCGCGTTCGCCGGGAAGTTCGCCGAGGACCGGGCCGCCCTCGCCCGGACCCTCTCCGCGTACAGCGCGCGGATGCGCTACAACACCTGGCACTACCTGCCGCACAGCATGTCGTGGACCGAGGAGTCCCCGGGCCGCGACGACTGGTTCTTCGCGCCGATGACGGCCGACATCACCAACTGGTCCGACCAGCACCACACCGGGCACGTCACCTTCGGCGTCCGGCACGCCCTGCGCATCCCGCTCGGCATCGTGCTGGAAGGCGCGTACCGCCCCGGCCTCTACGACCTGCGGCTGCTGCGCACCTCAGGCGCCGAGTTCGGGCAGGGCGACCTGCGGGCGGCCATGGTGGCCGGCCGGATCCAGGCGCTGCTGCACCAGGCGGCCGCCGACCGGGGCCTGGAGGTCCGCGATTTCGACAACGGCTGGTACCGGGATTTCCATGGCGCCTGA	MGLGERVYTEIAESQVAGFAPTGGPDTAADEGGGDLLVLTGTGRLRVVPAGTRPAGPEEAEPLGTLKWQNRPESLGRLWALAQDVQRIQFEEVHRWLAQQDAGSVRERIDAVGHALLHMAPVLLYVGDRFYSNLGKFSNLPGRSLAAGAERSVLTALRAAPAARWAPEDATFVVCLNALISSGSPVRAEEFNGVQLTPDLLAGFLRERIETYGAPVPDLAGRPTGAALDALAAACAAARAERLRAGAVFYREINGASLHKRERIMAEPLGWDELPAPVAGLLSGAAGRPFPVAAAPATVRAYAGEVVERVVRLAAPTGFTSAYEGFLHRFFETLAGALDCDVVMGRGPKSVAVLHSGHPAEDRIALATRDFYCCVAPGAAFAGKFAEDRAALARTLSAYSARMRYNTWHYLPHSMSWTEESPGRDDWFFAPMTADITNWSDQHHTGHVTFGVRHALRIPLGIVLEGAYRPGLYDLRLLRTSGAEFGQGDLRAAMVAGRIQALLHQAAADRGLEVRDFDNGWYRDFHGA	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	51.31	gnl|BL_ORD_ID|4683|hsp_num:0	1647			1254	1518	acriflavine; tetracycline; norfloxacin
BGC0000937.1|Fosfazinomycin_27 # 30680 # 31084 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.723	BGC0000937.1|Fosfazinomycin_27 	30680	31084	-	Loose	350	36.1946	SatA	25.93	3005045	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGTGGAAGTGTGAGCCCGTCGTCGGTGCCAGCCTCGACGTCGCCGAAGTCACCGCCCTGTACCGCGCGTCCACCCTCGGCGAGCGCCGTCCCGTCGAGGACGTCGAGCGGTTCACCCGGATGCTGGCCGGCGCCAACCTCGTGATCACGGCCCGCCTCGACGGGCGGCTCATCGGCATCGCGCGCTCGATCACCGACGGCTCGTACGTCACGTACCTGAGCGACATCGCCGTGGACGCCGAGTTCCAGCGCCGCGGCGTGGGCCGGGACCTGATCCGCGCCACCCGGGAGGCCGCGCCGCAGGCCAAGCTCGTGCTCCTCTCGGCCCCGGCCGCCGTCGCGTACTACCCGCACCTCGGGTTCAGCCGCCACGAGTCCGCATGGACCCTCGATGCGCTCGGCTGA	MWKCEPVVGASLDVAEVTALYRASTLGERRPVEDVERFTRMLAGANLVITARLDGRLIGIARSITDGSYVTYLSDIAVDAEFQRRGVGRDLIRATREAAPQAKLVLLSAPAAVAYYPHLGFSRHESAWTLDALG	MSLLIRELETNDLDNFPEIDDSFIVNARLMLSLSKVNRRIEYTVEDVPSYEKSYLQNDNEELVYNEYINKPNQIIYIALLHNQIIGFIVLKKNWNNYAYIEDITVDKKYRTLGVGKRLIAQAKQWAKEGNMPGIMLETQNNNVAACKFYEKCGFVIGGFDFLVYKGLNMTSDEVAIYWYLHFDS	72.83	gnl|BL_ORD_ID|2775|hsp_num:0	3788			219	462	streptothricin
BGC0000937.1|Fosfazinomycin_28 # 31071 # 32477 # -1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0000937.1|Fosfazinomycin_28 	31071	32477	-	Loose	500	29.6462	OXA-796	31.58	3005996	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAGTCCCGCAAGTCCAGTGAGACCCCCGAGCCCCATTCCCCCCCACGTCCCGTCCCCCGCCGTGCCGTCCGACGGGGAGATCCGAGGAGAACCGACCTTGATCGAACGCTATTCCACCCCGGAGCTGGCCGAGCTTTGGACCGAGGAGCACAAGTACGCCACCTGGACGCGCGTCGAGGTACTGGCGACGACCGCCCAGGCCGAACTCGGCGTCGTGGACCAGGGCAGCCTGGACGACATCCGCCGCGCCCCCGTCCCCGCCGTCGCCCGGGTCCGCGAGCTGGAACTCACCCGCGACCACGAGGTCCTCGCGTTCCTCGCGGCCTACACGGAGACGATGCCGGCCGCTTCCGCGCGCTGGGTGCACCACGGGATGACGAGCTACGACCTCGTCGACACCGCCCTCGGACACATCCTGGCGCGCTCGTGCGACCACGTGCTGAATGCCGCCCGTACGTTCGCCGAACTGCTCGTGGAGCGCGCCCTGGAGCACTGGGACACGGTGTGCATCGCCCGCACCCACGGCATCCACGCCGAGCCCACCACCTTCGGGCAGAAGCTCGCCGTGCACGCCTTCGCCCTCCACCGCAGCATCGCCCGGCTGACCGCCGCCCGGGCCGCCGTGGCCGTCGGCACCGTCTCCGGGCCGGTCGGCACGTACGCGCACATCTCCCCGTACGTCGAGCAGTGGGTCTGCGGGCAACTCGGCCTCGGCGTCGAGCCGATGCCCACCCAGGTCGTGGCCCGGGACCGGCACGCCGAGCTGCTCTCCGCGCTCGCCGTGACGGGCGCCGTCGTCGAGCAGTTCGCCCTGGAGATGCGGATGCTCCAGCGCACCGAGGTCGGGGAGGTCGACGAGCCGCGCACCAGCGCCTACCAGGGGTCGAGCGCGATGCCGCACAAGCGGAACCCGACGACCAGCGAGCGGCTGTGCGGTCTGGCCCGGATCCTGCGCTCCAATGCCGGCGCGGCCTACGAGAACGTCGCGCTGTGGCACGAGCGGGACCTCGCGCACTCCTCCGTGGAGCGGGTCATCCTGCCCGACAGCCTGACCGTGGCCCACTACCAGCTCGTCTCGGCCGCCGGACTGCTGCGCGGGCTGCGGGTGTTCCCCGAGCGCATGGCGCGCAACATCGACGCCACCCGGGGCCTGGTCTACAGCTCCGAGGTGTTCCTGGACCTCGTCGACGGGGGCCGGGACCGCGAGGAGGCCTACCGGCTGGTCCAGGCCGCGGCCACCGAGGCGTGGGAGCGCGGCACGAGCCTGGCCGAGGGCCTCGGCTCCCGCGGTGTGGACGTCACCGCCGATCACATGGACCCGCGGCGCTTCCTCGGAAACCGCGACCACCTCAAATCCCGGCTGAACGAACTGAGCAAGGAGCTGCAGCAGCATGTGGAAGTGTGA	MSPASPVRPPSPIPPHVPSPAVPSDGEIRGEPTLIERYSTPELAELWTEEHKYATWTRVEVLATTAQAELGVVDQGSLDDIRRAPVPAVARVRELELTRDHEVLAFLAAYTETMPAASARWVHHGMTSYDLVDTALGHILARSCDHVLNAARTFAELLVERALEHWDTVCIARTHGIHAEPTTFGQKLAVHAFALHRSIARLTAARAAVAVGTVSGPVGTYAHISPYVEQWVCGQLGLGVEPMPTQVVARDRHAELLSALAVTGAVVEQFALEMRMLQRTEVGEVDEPRTSAYQGSSAMPHKRNPTTSERLCGLARILRSNAGAAYENVALWHERDLAHSSVERVILPDSLTVAHYQLVSAAGLLRGLRVFPERMARNIDATRGLVYSSEVFLDLVDGGRDREEAYRLVQAAATEAWERGTSLAEGLGSRGVDVTADHMDPRRFLGNRDHLKSRLNELSKELQQHVEV	MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL	169.57	gnl|BL_ORD_ID|4031|hsp_num:0	5101			246	360	cloxacillin; oxacillin; cefalotin
BGC0000937.1|Fosfazinomycin_29 # 32535 # 33656 # -1 # ID=1_29;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.766	BGC0000937.1|Fosfazinomycin_29 	32535	33656	-	Loose	800	27.335	msrA	26.09	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	ATCCGGCGGCTGCGCGACGTCTCCCGGGAGGGCGCGGAGCGCACCGTCCCGCAGACGCTCAACCTGTACGGGGCCGCCGGAGTCGGCAAGACCACCATGGCGGTCCGGGTCGCCCACGCCGTCAGCCCCGCCTTCCCCGACGGCCAGCTGTACGTCGAGCTCCAGCGCGGCGACGCCTTCCGCGAGCCGGCGGACGTGCTCGGCGAGCTGCTCCGCGCGCTCGGCGTCGGCCCCGGCGCCGTGCCCGCCGACTCCGGCGAACGGGTGGCCCTGTACCGGGGGCTGCTCTCCCACCGGCGCGTGCTGATCGTGCTGGACGGGGCGCGCGACGAGGCGCAGGTACGTCCGCTGCTGCCGGCCTCGCCGACCTGCGCGGCCGTGGTGACCAGCCTGGAGATGCTGTCCACCCTGGGCGGCACCCGGCACGTGCGCCTCGGACTGCTGACCGCGGAGGAGTCCCGCGAGATCCTGGCCCGGATGCTCGGCCGCGAGCGGGTGGCGGCGGAGGAGGGGGCCGCGCAGGACCTGGTGCGGTACTGCGGCCGGCTGCCGCTGGCGATCCGGATCGTCGGGGCGCGCCTGCTGGAGCGCCCGCACTGGCGGCTGGAGACGCTCGCCCGGCGGCTGGAGTCGGAGCGCAGGAGGCTCGACGAGCTGGCGGTCGGCGACCTCGGCGTCCGCGACAGCCTGGCAGTCGGCTACGCGGCGCTGGAGGTCCCGGAGCGCAGGGCGTTCCGGCTGCTCAGCCTGCTGGAGACGGCCTCGTTCCCGGTCCGGGTGGCCGCGGCCGCGCTGGGGCTGCCGGACGACCGCACGGAGGAGACCCTGGAGCGGCTGACCGCGCAGCACCTGCTGGAGGCCGACTTCGTCAAGGGCAGCGGGGTGCGCTTCTCGTACCACCCGCTGGTCCGGCTGTACGCGCGGGAGCTCACGTTCGACGTGGACCCGATGCCGAGCCGGCACGGCGCGGTGCAGAACGCGCTGGCCGCCTGGTACGCGAGACCGGCCGGAGCGCTGGTCCCGCTGCGGGCCACTCCCTCCGCGGGCGGCCCGGCGGCCCGCACCGAAGCCGTCGCCGCCGCGGCGAGCCCGTTGCCACCGGAGCTCGGCTTCACCGCCTGA	IRRLRDVSREGAERTVPQTLNLYGAAGVGKTTMAVRVAHAVSPAFPDGQLYVELQRGDAFREPADVLGELLRALGVGPGAVPADSGERVALYRGLLSHRRVLIVLDGARDEAQVRPLLPASPTCAAVVTSLEMLSTLGGTRHVRLGLLTAEESREILARMLGRERVAAEEGAAQDLVRYCGRLPLAIRIVGARLLERPHWRLETLARRLESERRRLDELAVGDLGVRDSLAVGYAALEVPERRAFRLLSLLETASFPVRVAAAALGLPDDRTEETLERLTAQHLLEADFVKGSGVRFSYHPLVRLYARELTFDVDPMPSRHGAVQNALAAWYARPAGALVPLRATPSAGGPAARTEAVAAAASPLPPELGFTA	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	76.43	gnl|BL_ORD_ID|1105|hsp_num:0	1200			105	381	erythromycin; quinupristin
